Quick Dispatch:
Your tirzepatide hfpef trial STEP-HFpEF Trial orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide hfpef trial STEP-HFpEF Trial ships.
Need Help?
Questions about tirzepatide hfpef trial STEP-HFpEF Trial, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide hfpef trial STEP-HFpEF Trial in your area.
Real-world outcomes for GLP‑1 therapies in HFpEF and T2DM published in @JAMA_current: In >97k U.S. patients, semaglutide & tirzepatide each reduced HF hospitalization/all-cause mortality by >40% vs sitagliptin — confirming STEP‑HFpEF DM
21.27
Effectiveness of tirzepatide in patients with HFpEF using a target trial emulation retrospective cohort study
23.36
Eli Lilly's tirzepatide showed positive results in late-stage trial as treatment for heart failure
28.45
SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide
25.23
AHA 24 Late-Breaking Discussion: SUMMIT: Tirzepatide in Patients with HFpEF and Obesity
27.98
ICYMI: Eli Lilly's tirzepatide showed a 38% reduction in heart failure outcomes and improved symptoms in adults with #HFpEF and #obesity in the phase 3 SUMMIT trial. https://t.co/W4My4YF2Ks
27.27
🧬 New data from the SUMMIT trial reveals that long-term tirzepatide (Zepbound) may significantly improve kidney function in patients with obesity, chronic kidney disease (CKD), and heart failure with preserved ejection fraction (
24.92
00188-2/asset/060af149-96d8-44a2-9e4d-318ecc8ae69e/main.assets/gr1_lrg.jpg)
